162 related articles for article (PubMed ID: 2437563)
1. Effect of a new somatostatin analogue on pancreatic function in healthy volunteers.
Köhler E; Beglinger C; Dettwiler S; Whitehouse I; Gyr K
Pancreas; 1986; 1(2):154-9. PubMed ID: 2437563
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995).
Kemmer TP; Malfertheiner P; Büchler M; Friess H; Meschenmoser L; Ditschuneit H
Aliment Pharmacol Ther; 1992 Feb; 6(1):41-50. PubMed ID: 1371938
[TBL] [Abstract][Full Text] [Related]
3. Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion.
Konturek SJ; Bilski J; Jaworek J; Tasler J; Schally AV
Proc Soc Exp Biol Med; 1988 Feb; 187(2):241-9. PubMed ID: 2448802
[TBL] [Abstract][Full Text] [Related]
4. A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man.
Vatn MH; Schrumpf E; Hanssen KF; Myren J
J Endocrinol Invest; 1980; 3(3):279-82. PubMed ID: 6159391
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic secretory responses to long-term infusions of secretin and cerulein in humans.
Adler G; Drewe J; Steinmetz A; Liyanage K; Beglinger C
Pancreas; 1990 Nov; 5(6):685-92. PubMed ID: 1704124
[TBL] [Abstract][Full Text] [Related]
6. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs.
Misumi A; Shiratori K; Lee KY; Barkin JS; Chey WY
Surgery; 1988 Apr; 103(4):450-5. PubMed ID: 2895501
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats.
Shiratori K; Watanabe S; Takeuchi T
Pancreas; 1991 Jan; 6(1):23-30. PubMed ID: 1704631
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin 14 on pure human pancreatic secretion.
Gullo L; Priori P; Scarpignato C; Baldoni F; Mattioli G; Barbara L
Dig Dis Sci; 1987 Oct; 32(10):1065-70. PubMed ID: 2888607
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute hyperglycemia on basal, secretin and secretin + cholecystokinin stimulated exocrine pancreatic secretion in humans.
Lam WF; Masclee AA; Souverijn JH; Lamers CB
Life Sci; 1999; 64(8):617-26. PubMed ID: 10069525
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of somatostatin analogue, SMS 201-995, on secretin-stimulated exocrine secretion in isolated perfused rat pancreas].
Hasegawa H; Okabayashi Y; Koide M; Kido Y; Okutani T; Matsushita K; Sugimoto Y; Nakamura T; Otsuki M; Kasuga M
Nihon Shokakibyo Gakkai Zasshi; 1993 May; 90(5):1425-31. PubMed ID: 8320851
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of terbutaline-induced inhibition of exocrine pancreatic secretion in humans.
Meyer B; Hildebrand P; Meyer M; Stalder GA; Beglinger C
Pancreas; 1988; 3(4):399-403. PubMed ID: 2902621
[TBL] [Abstract][Full Text] [Related]
13. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog.
Kayasseh L; Gyr K; Stalder GA; Rittmann WW; Girard J
Horm Res; 1978; 9(3):176-84. PubMed ID: 640582
[TBL] [Abstract][Full Text] [Related]
14. Circulating somatostatin. Physiological regulator of pancreatic function?
Gyr K; Beglinger C; Köhler E; Trautzl U; Keller U; Bloom SR
J Clin Invest; 1987 Jun; 79(6):1595-600. PubMed ID: 2884233
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous nitric oxide in the control of exocrine and endocrine pancreatic secretion in humans.
Konturek JW; Hengst K; Kulesza E; Gabryelewicz A; Konturek SJ; Domschke W
Gut; 1997 Jan; 40(1):86-91. PubMed ID: 9155581
[TBL] [Abstract][Full Text] [Related]
16. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.
Lembcke B; Creutzfeldt W; Schleser S; Ebert R; Shaw C; Koop I
Digestion; 1987; 36(2):108-24. PubMed ID: 2883060
[TBL] [Abstract][Full Text] [Related]
17. Effect of somatostatin and octreotide acetate on OP-CCK-stimulated exocrine secretion in the denervated canine pancreas.
Garvin PJ; Burton FR; Reese JC; Dysarz FA; Lingle D; Niehoff ML; Pandya PK; Presti ME
Pancreas; 1996 Oct; 13(3):304-10. PubMed ID: 8884853
[TBL] [Abstract][Full Text] [Related]
18. Total denervation of the pancreas does not alter the pancreatic polypeptide-induced inhibition of pancreatic exocrine secretion in dogs.
Köhler H; Nustede R; Barthel M; Müller C; Schafmayer A
Res Exp Med (Berl); 1991; 191(5):359-69. PubMed ID: 1759047
[TBL] [Abstract][Full Text] [Related]
19. The effect of graded doses of secretin on serum trypsin, serum pancreatic amylase, serum insulin, plasma somatostatin, and plasma pancreatic polypeptide in man.
Florholmen J; Burhol PG; Jorde R; Waldum HL
Scand J Gastroenterol; 1984 Jan; 19(1):24-30. PubMed ID: 6200924
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide.
Adrian TE; Besterman HS; Mallinson CN; Greenberg GR; Bloom SR
Gut; 1979 Jan; 20(1):37-40. PubMed ID: 761835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
